Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
CPhI: DSM Sinochem Pharmaceuticals to build Atorvastatin facility in India
8:06 AM MDT | October 15, 2012 | Deepti Ramesh in Madrid
DSM Sinochem Pharmaceuticals (DSP; Singapore), the former DSM Anti-Infectives business, says that it is planning to build production capacity for manufacturing the active pharmaceutical ingredient (API) for atorvastatin, the generic version of cholesterol-lowering drug Lipitor, at DSP’s existing production facility at Toansa, India. Pfizer’s Lipitor has been the top-selling drug worldwide. DSP says it is also considering manufacturing the finished dosage form of atorvastatin. “[Atorvastatin] will be an important business for the company and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee